Biotech Press Releases

Arsenale Bioyards a neo-industrial company fundamentally redefining scalable biomanufacturing, has announced the successful closure of its first $10 million seed financing round.

NEXS BioMedica, a forward-thinking biotech pharmaceutical company, proudly introduces CancerScope-AI, an innovative artificial intelligence system set to transform the battle against rare cancers.

NeuroZenn is now available for all Veterans to have prescribed for nerve pain at all veteran Affairs Hospitals.

Comprehensive insights into market growth, breakthrough innovations, funding trends, and intellectual property shaping the future of synthetic biology.

As per DPI Research's latest published report, the Australia Non-Invasive Prenatal Testing (NIPT) market size was valued at USD 57.8 million in 2024 and is projected to hit around USD 83.3 million by 2033, growing at a CAGR of 4.1%

Pharma groups play a essential function in clinical services, ensuring that medicines attain individuals who need them.

In the fast-moving biotechnology world, where speed and precision are key, Creative Biolabs is making waves with its high throughput antibody production services.

Biovenic, a powerhouse in veterinary research, transforms the way to detect and manage animal diseases.

Sano Women's Health has received investigational new drug approval from the FDA, for Occidiofungin, a first-in-class novel peptide with broad antifungal activity.

Curtana Pharmaceuticals, a biotechnology company focused on improving outcomes for brain cancer patients, is proud to announce the publication of two pioneering studies in Nature Communications.

The global CT scanner market was valued at USD 6.94 billion in 2024 and is projected to grow at a CAGR of 6.8% from 2025 to 2032, reaching an estimated value of USD 11.75 billion by the end of the forecast period.

Manhattan BioSolutions, Inc. ("MABS"), an emerging biotechnology company developing new classes of precision biologics that harness natural host defense mechanisms, today announced that its RNA-targeting therapeutic, MABS-139, will be evaluated in...

Disrupting the healthcare consulting landscape, Improzo Inc. is rapidly gaining traction with its innovative approach that tackles modern challenges and prioritizes patients.

Oak Therapeutics, a pioneering early-stage life sciences company, announces the successful development of an innovative Oral Dissolvable Strip (ODS) formulation for the treatment of HIV/AIDS in infants and young children.

$NRXP given a $31 Price Target from Respected Investment Analyst D. Boral Capital

Five leaders honored as champions of small business and non-profit ecosystems

The global diabetes insulin delivery pen market size was valued at USD 17.7 Billion in 2023 and is likely to reach USD 28.7 Billion in 2032, expanding at a CAGR 5.5% during the forecast period.

A 250 million year old dragon fossil was added to the PermianMuseum.com "On the Origin of Life and Biodiversity"  free online book.

15,000 smiles and counting: OneSolution® Dental Implant Centers marks an important milestone in the number of life-changing full-mouth implant procedures performed for patients, setting the standard of care expected in South Florida.

Ventura & Associates HTA Advisors is thrilled to announce its joining of the Microsoft AI Cloud Partner Program and the Microsoft Fabric Community.

Tracks recent competitive developments, approaches, recent industry developments, mergers & acquisitions, collaboration deals, partnership deals, distribution, exclusive, and licensing agreement

Market dynamics indicate a continued expansion in the NIPT sector, with forecasts suggesting that the market could reach approximately US$2.8 billion by 2033, representing a compound annual growth rate (CAGR) of approximately 10.5%

Discover how AI is transforming clinical research at ISCR 2025, with Clinion at the forefront of innovation and patient engagement.

Clinion has been recognised with the prestigious SCDM Innovation Award for Clinical Data Science Implementation Excellence at the 2024 SCDM Annual Conference in Boston.

The United States proton therapy market size was valued at USD 1 billion in 2024 and is projected to hit around USD 2.5 billion by 2033, growing at a CAGR of 12% during the forecast period 2025 to 2033.

Immunology Consultants Laboratory, a leading provider of innovative antibodies and immunoassays, is excited to announce the appointment of Dr. Eric McIntush as its new Chief Executive Officer (CEO), effective January 13, 2025. Dr.

$NRXP $31 Price Target from Respected Investment Analyst D. Boral Capital

Milestone Positions Company for Broader Clinical Adoption and Strategic Growth

Maureen L. Mulvihill, Ph.D., President & CEO of Actuated Medical, has been named Chair of the Industrial Advisory Board for the Penn State Center for Biodevices. A founding member of the board since its inception in August 2020, Dr.

$NRXP New Drug Application for Treatment of Suicidal Depression. Completion of NDA Filing Expected in First Quarter of 2025

NRx Pharmaceuticals, Inc.: Stock Symbol: NRXP IS Aiming to be the First FDA-Approved Medication to Treat Suicidal Depression